Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion

Christina Bruß(University Hospital Regensburg), Anja K. Wege(University of Regensburg)
Cancers
May 4, 2023
10.3390/cancers15092615
Cited by 19

Related Papers

Humanized tumor mice—A new model to study and manipulate the immune response in advanced cancer therapy
|International Journal of Cancer|2011|105
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
|Breast Cancer Research|2018|19
Neoadjuvant radiotherapy in ER+, HER2+, and triple-negative -specific breast cancer based humanized tumor mice enhances anti-PD-L1 treatment efficacy
|Frontiers in Immunology|2024|7